NHS England has updated the Cancer Drugs Fund List to version 1.379.
https://updates.chemo.org.uk/news/CDFNews_1.379.html
Changes - 👇 🧵
NHS England has updated the Cancer Drugs Fund List to version 1.379.
https://updates.chemo.org.uk/news/CDFNews_1.379.html
Changes - 👇 🧵
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-24.html
Changes: glatiramer acetate, melphalan hydrochloride, rozanolixizumab, ciltacabtagene autoleucel, afatin...
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-24.html
Changes: glatiramer acetate, melphalan hydrochloride, rozanolixizumab, ciltacabtagene autoleucel, afatin...
8 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-20.html
Changes: azathioprine, fluorouracil, mogamulizumab, bacillus calmette-guerin, daratumumab, glatiramer ac...
8 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-20.html
Changes: azathioprine, fluorouracil, mogamulizumab, bacillus calmette-guerin, daratumumab, glatiramer ac...
NHS England has updated the Cancer Drugs Fund List to version 1.378.
https://updates.chemo.org.uk/news/CDFNews_1.378.html
Changes - 👇 🧵
NHS England has updated the Cancer Drugs Fund List to version 1.378.
https://updates.chemo.org.uk/news/CDFNews_1.378.html
Changes - 👇 🧵
NHS England has updated the Cancer Drugs Fund List to version 1.377.
https://updates.chemo.org.uk/news/CDFNews_1.377.html
Changes - 👇 🧵
NHS England has updated the Cancer Drugs Fund List to version 1.377.
https://updates.chemo.org.uk/news/CDFNews_1.377.html
Changes - 👇 🧵
10 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-17.html
Changes: fingolimod hydrochloride, ruxolitinib phosphate, glofitamab, alpelisib, azathioprine, fluorour...
10 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-17.html
Changes: fingolimod hydrochloride, ruxolitinib phosphate, glofitamab, alpelisib, azathioprine, fluorour...
25 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-13.html
Changes: methotrexate, larotrectinib sulfate, methotrexate disodium, teclistamab, afatinib dimaleate, l...
25 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-13.html
Changes: methotrexate, larotrectinib sulfate, methotrexate disodium, teclistamab, afatinib dimaleate, l...
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-10.html
Changes: dimethyl fumarate, ropeginterferon alfa-2b, cisplatin, elranatamab, methotrexate
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-10.html
Changes: dimethyl fumarate, ropeginterferon alfa-2b, cisplatin, elranatamab, methotrexate
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-06.html
Changes: fluorouracil, Ublituximab, fulvestrant, melphalan hydrochloride, dimethyl fumarate, ropeginterf...
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-06.html
Changes: fluorouracil, Ublituximab, fulvestrant, melphalan hydrochloride, dimethyl fumarate, ropeginterf...
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-03.html
Changes: teriflunomide, bevacizumab, fluorouracil, fulvestrant
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-03.html
Changes: teriflunomide, bevacizumab, fluorouracil, fulvestrant
4 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-30.html
Changes: pertuzumab, apalutamide, teriflunomide, bevacizumab
4 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-30.html
Changes: pertuzumab, apalutamide, teriflunomide, bevacizumab
3 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-27.html
Changes: triptorelin acetate, pertuzumab, fluorouracil
3 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-27.html
Changes: triptorelin acetate, pertuzumab, fluorouracil
NHS England has updated the Cancer Drugs Fund List to version 1.376.
https://updates.chemo.org.uk/news/CDFNews_1.376.html
Changes - 👇 🧵
NHS England has updated the Cancer Drugs Fund List to version 1.376.
https://updates.chemo.org.uk/news/CDFNews_1.376.html
Changes - 👇 🧵
7 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-23.html
Changes: amivantamab, rituximab, nivolumab, triptorelin acetate, pertuzumab
7 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-23.html
Changes: amivantamab, rituximab, nivolumab, triptorelin acetate, pertuzumab
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-20.html
Changes: Leniolisib phosphate, dimethyl fumarate, natalizumab, amivantamab
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-20.html
Changes: Leniolisib phosphate, dimethyl fumarate, natalizumab, amivantamab
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-16.html
Changes: mycophenolate mofetil, trabectedin, Leniolisib phosphate, dimethyl fumarate
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-16.html
Changes: mycophenolate mofetil, trabectedin, Leniolisib phosphate, dimethyl fumarate
9 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-13.html
Changes: cytarabine, tivozanib hydrochloride monohydrate, eribulin, rituximab, mycophenolate mofetil, tr...
9 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-13.html
Changes: cytarabine, tivozanib hydrochloride monohydrate, eribulin, rituximab, mycophenolate mofetil, tr...
NHS England has updated the Cancer Drugs Fund List to version 1.375.
https://updates.chemo.org.uk/news/CDFNews_1.375.html
Changes - 👇 🧵
NHS England has updated the Cancer Drugs Fund List to version 1.375.
https://updates.chemo.org.uk/news/CDFNews_1.375.html
Changes - 👇 🧵
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-09.html
Changes: nivolumab, atezolizumab, amivantamab, cytarabine
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-09.html
Changes: nivolumab, atezolizumab, amivantamab, cytarabine
3 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-06.html
Changes: belimumab, nivolumab, tivozanib hydrochloride monohydrate
3 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-06.html
Changes: belimumab, nivolumab, tivozanib hydrochloride monohydrate
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-02.html
Changes: cabozantinib, selpercatinib, belimumab, nivolumab
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-10-02.html
Changes: cabozantinib, selpercatinib, belimumab, nivolumab
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-09-29.html
Changes: fingolimod hydrochloride, anastrozole, cabozantinib, belimumab
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-09-29.html
Changes: fingolimod hydrochloride, anastrozole, cabozantinib, belimumab
3 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-09-25.html
Changes: hydroxycarbamide, fingolimod hydrochloride, belimumab
3 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-09-25.html
Changes: hydroxycarbamide, fingolimod hydrochloride, belimumab
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-09-22.html
Changes: dabrafenib mesilate, Idecabtagene vicleucel, niraparib tosylate monohydrate, hydroxycarbamide
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-09-22.html
Changes: dabrafenib mesilate, Idecabtagene vicleucel, niraparib tosylate monohydrate, hydroxycarbamide
NHS England has updated the Cancer Drugs Fund List to version 1.374.
https://updates.chemo.org.uk/news/CDFNews_1.374.html
Changes - 👇 🧵
NHS England has updated the Cancer Drugs Fund List to version 1.374.
https://updates.chemo.org.uk/news/CDFNews_1.374.html
Changes - 👇 🧵